MDGL
Madrigal Pharmaceuticals Inc
NASDAQ: MDGL · HEALTHCARE · BIOTECHNOLOGY
$518.58
+0.37% today
Updated 2026-04-29
Market cap
$11.96B
P/E ratio
—
P/S ratio
12.48x
EPS (TTM)
$-12.87
Dividend yield
—
52W range
$265 – $615
Volume
0.4M
Madrigal Pharmaceuticals Inc (MDGL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $71.21M | $54.79M | $122.65M | $97.25M | $48.91M | $54.07M | $42.32M | $103.02M | $95.20M | $100.67M | $68.19M | $41.21M | $192.31M | $485.43M | $442.06M | $287.00M | $273.33M | $362.57M | $640.55M | $1.04B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $62.95M | $47.63M | $117.00M | $91.22M | $44.57M | $51.52M | $40.29M | $101.39M | $92.24M | $99.35M | $363581.00 | $41.21M | $192.01M | $485.20M | $440.20M | $285.16M | $271.68M | $361.37M | $637.28M | $1.03B |
| Total liabilities | $18.73M | $56.54M | $97.75M | $156.04M | $24.00M | $30.59M | $27.55M | $27.95M | $46.11M | $35.54M | $17.79M | $4.80M | $10.05M | $8.44M | $25.49M | $47.02M | $77.22M | $165.18M | $235.21M | $287.86M |
| Current liabilities | $14.47M | $11.55M | $20.77M | $33.32M | $16.47M | $16.74M | $15.15M | $23.49M | $32.21M | $30.89M | $49.28M | $4.80M | $10.05M | $8.44M | $25.13M | $46.56M | $76.84M | $115.89M | $118.55M | $169.28M |
| Long-term debt | — | — | — | — | — | — | $12.39M | $4.46M | $0.00 | $42.19M | $0.00 | $0.00 | $0.00 | — | — | — | — | $49.29M | $115.48M | $117.57M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-179.29M | $-236.56M | $-300.05M | $-392.67M | $-313.58M | $-351.05M | $-398.43M | $-461.22M | $-551.41M | $-637.57M | $-706.24M | $-75.31M | $-106.46M | $-139.27M | $-223.22M | $-425.46M | $-667.31M | $-962.66M | $-1.34B | $-1.80B |
| Accounts receivable | — | — | — | $16.00M | — | $116000.00 | — | — | — | $46155.00 | $7332.00 | — | — | — | — | — | — | — | $0.00 | $53.82M |
| Inventory | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $-7332.00 | $0.00 | $0.00 | — | — | — | — | — | $0.00 | $34.07M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |